| scholarly article | Q13442814 |
| P50 | author | Wolfgang Sadee | Q57715733 |
| P2093 | author name string | H Zhu | |
| D Sullivan | |||
| A C Papp | |||
| S Lemeshow | |||
| D C Mash | |||
| J K Pinsonneault | |||
| P2860 | cites work | Finding the missing heritability of complex diseases | Q22122198 |
| Dopamine transporter cell surface localization facilitated by a direct interaction with the dopamine D2 receptor | Q24300744 | ||
| How addictive drugs disrupt presynaptic dopamine neurotransmission | Q24631269 | ||
| Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene | Q27860482 | ||
| Distinct functions of the two isoforms of dopamine D2 receptors | Q28138415 | ||
| The evolutionary significance of cis-regulatory mutations | Q28288545 | ||
| The mystery of missing heritability: Genetic interactions create phantom heritability | Q28732355 | ||
| Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats | Q29619737 | ||
| Catecholamine receptor polymorphisms affect decision-making in C. elegans | Q30503390 | ||
| Genetic polymorphisms in the dopamine-2 receptor (DRD2), dopamine-3 receptor (DRD3), and dopamine transporter (SLC6A3) genes in schizophrenia: Data from an association study | Q33505008 | ||
| Functional variation of the dopamine D2 receptor gene is associated with emotional control as well as brain activity and connectivity during emotion processing in humans | Q33711011 | ||
| Stimulant abuse: pharmacology, cocaine, methamphetamine, treatment, attempts at pharmacotherapy | Q34167229 | ||
| A dopamine transporter gene functional variant associated with cocaine abuse in a Brazilian sample. | Q34574817 | ||
| Multicenter analysis of the SLC6A3/DAT1 VNTR haplotype in persistent ADHD suggests differential involvement of the gene in childhood and persistent ADHD. | Q34661589 | ||
| Impact of the COMT Val108/158 Met and DAT genotypes on prefrontal function in healthy subjects. | Q34661594 | ||
| Intronic polymorphisms affecting alternative splicing of human dopamine D2 receptor are associated with cocaine abuse | Q34662050 | ||
| Dopamine transporter gene variant affecting expression in human brain is associated with bipolar disorder | Q35112181 | ||
| Pharmacogenomics of the RNA world: structural RNA polymorphisms in drug therapy | Q35654120 | ||
| Gene-gene interaction associated with neural reward sensitivity | Q35781505 | ||
| Epistatic interactions of AKT1 on human medial temporal lobe biology and pharmacogenetic implications | Q36253904 | ||
| Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory. | Q36300098 | ||
| Prominence of the dopamine D2 short isoform in dopaminergic pathways | Q36507451 | ||
| Genetically determined interaction between the dopamine transporter and the D2 receptor on prefronto-striatal activity and volume in humans. | Q37201805 | ||
| The genetic basis of addiction and relevant cellular mechanisms | Q37829267 | ||
| Functional analysis of intron 8 and 3' UTR variable number of tandem repeats of SLC6A3: differential activity of intron 8 variants | Q39759956 | ||
| D2 receptors regulate dopamine transporter function via an extracellular signal-regulated kinases 1 and 2-dependent and phosphoinositide 3 kinase-independent mechanism. | Q40176514 | ||
| Brain dopamine transporter messenger RNA and binding sites in cocaine users: a postmortem study. | Q42539746 | ||
| No association of the dopamine transporter gene 3' VNTR polymorphism with ADHD subtypes in a population sample of twins | Q43861865 | ||
| Cocaine induction of dopamine transporter trafficking to the plasma membrane | Q43865629 | ||
| Dopamine transport function is elevated in cocaine users | Q44027693 | ||
| Elevated striatal dopamine transporters during acute cocaine abstinence as measured by [123I] beta-CIT SPECT. | Q44748980 | ||
| National Association of Medical Examiners position paper on the certification of cocaine-related deaths | Q44838559 | ||
| Interacting effects of the dopamine transporter gene and psychosocial adversity on attention-deficit/hyperactivity disorder symptoms among 15-year-olds from a high-risk community sample | Q44985331 | ||
| The role of dopamine transporter (SLC6A3) and dopamine D2 receptor/ankyrin repeat and kinase domain containing 1 (DRD2/ANKK1) gene polymorphisms in personality traits | Q45201727 | ||
| Sequence variation in the 3'-untranslated region of the dopamine transporter gene and attention-deficit hyperactivity disorder (ADHD). | Q46636731 | ||
| Relationship between VNTR polymorphisms of the human dopamine transporter gene and expression in post-mortem midbrain tissue | Q48131633 | ||
| Loss of autoreceptor functions in mice lacking the dopamine transporter | Q48163806 | ||
| Interactive effects of DAOA (G72) and catechol-O-methyltransferase on neurophysiology in prefrontal cortex. | Q51024502 | ||
| Mapping dopamine transporters in the human brain with novel selective cocaine analog [125I]RTI-121. | Q51585551 | ||
| High affinity cocaine recognition sites on the dopamine transporter are elevated in fatal cocaine overdose victims. | Q51617568 | ||
| Cocaine use increases [3H]WIN 35428 binding sites in human striatum. | Q51650264 | ||
| D2 dopamine receptor gene haplotypes and their influence on alcohol and tobacco consumption magnitude in alcohol-dependent individuals | Q80384984 | ||
| P921 | main subject | cocaine dependence | Q3743188 |
| P304 | page(s) | e222 | |
| P577 | publication date | 2013-01-22 | |
| P1433 | published in | Translational Psychiatry | Q15716636 |
| P1476 | title | Dopamine transporter DAT and receptor DRD2 variants affect risk of lethal cocaine abuse: a gene-gene-environment interaction | |
| P478 | volume | 3 |
| Q38348213 | A review of co-morbid tobacco and cannabis use disorders: possible mechanisms to explain high rates of co-use |
| Q35731672 | Analyzing allele specific RNA expression using mixture models |
| Q33854534 | Association of dopamine gene variants, emotion dysregulation and ADHD in autism spectrum disorder |
| Q35733219 | Carriers of a common variant in the dopamine transporter gene have greater dementia risk, cognitive decline, and faster ventricular expansion |
| Q36100262 | Clinically Combating Reward Deficiency Syndrome (RDS) with Dopamine Agonist Therapy as a Paradigm Shift: Dopamine for Dinner? |
| Q36402504 | Common variants in DRD2 are associated with sleep duration: the CARe consortium |
| Q30278827 | Comparison of dopamine kinetics in the larval Drosophila ventral nerve cord and protocerebrum with improved optogenetic stimulation |
| Q33599626 | DRD2/CHRNA5 interaction on prefrontal biology and physiology during working memory |
| Q39619848 | Dopamine D3 autoreceptor inhibition enhances cocaine potency at the dopamine transporter. |
| Q27003334 | Dopamine and glucose, obesity, and reward deficiency syndrome |
| Q58115044 | Effects of DRD2 splicing-regulatory polymorphism and DRD4 48 bp VNTR on crack cocaine addiction |
| Q39309327 | Gene polymorphisms associated with temperament. |
| Q38292930 | Genomic architecture of pharmacological efficacy and adverse events |
| Q34304684 | Hatching the behavioral addiction egg: Reward Deficiency Solution System (RDSS)™ as a function of dopaminergic neurogenetics and brain functional connectivity linking all addictions under a common rubric. |
| Q59807426 | Introducing Precision Addiction Management of Reward Deficiency Syndrome, the Construct That Underpins All Addictive Behaviors |
| Q36404935 | Methods to analyze big data in pharmacogenomics research |
| Q33676705 | MicroRNA-9 and microRNA-326 regulate human dopamine D2 receptor expression, and the microRNA-mediated expression regulation is altered by a genetic variant |
| Q34212558 | Missing heritability of common diseases and treatments outside the protein-coding exome |
| Q64101391 | Quantification of allelic differential expression using a simple Fluorescence primer PCR-RFLP-based method |
| Q35849067 | RNA sequencing of transcriptomes in human brain regions: protein-coding and non-coding RNAs, isoforms and alleles |
| Q40519250 | Rapporteur summaries of plenary, symposia, and oral sessions from the XXIIIrd World Congress of Psychiatric Genetics Meeting in Toronto, Canada, 16-20 October 2015. |
| Q38243174 | Should we keep on? Looking into pharmacogenomics of ADHD in adulthood from a different perspective. |
| Q38982760 | Single nucleotide polymorphisms in the FcγR3A and TAP1 genes impact ADCC in cynomolgus monkey PBMCs |
| Q33579769 | The dopamine receptor D2 (DRD2) SNP rs1076560 is associated with opioid addiction |
| Q54947826 | The frequency of DRD2 rs1076560 and OPRM1 rs1799971 in substance use disorder patients from the United Arab Emirates. |
| Q30277983 | The significant association of Taq1A genotypes in DRD2/ANKK1 with smoking cessation in a large-scale meta-analysis of Caucasian populations |
| Q42201173 | Updated findings of the association and functional studies of DRD2/ANKK1 variants with addictions |
| Q64079797 | Variability in the Drug Response of M Muscarinic Receptor Knockout Mice During Day and Night Time |
Search more.